Company Overview and News

 
Pilgangoora maiden delivery achieves impressive results

2018-10-09 australianmining.com.au
Pilbara Minerals’ first spodumene concentrate shipment from the Pilgangoora lithium-tantalum project in Western Australia has achieved impressive results following independent testing.
PLS PILBF

 
Altura loads first lithium shipment at Port Hedland

2018-10-04 australianmining.com.au
Altura Mining is on the verge of shipping its maiden cargo of spodumene concentrate from the Pilgangoora lithium project in the Pilbara, Western Australia.
PLS PILBF ALTAF AJM

 
First Pilbara Minerals shipment bound for Asia

2018-10-02 australianmining.com.au
Pilbara Minerals is celebrating the first shipment of spodumene concentrate from its Pilgangoora lithium-tantalum project in Western Australia leaving Port Hedland.
PLS PILBF

 
Australian lithium opportunity worth ‘hundreds of billions’

2018-10-02 australianmining.com.au
Australia needs to make key decisions about the future of its lithium sector in the coming months to capitalise on the huge economic potential, according to the Australian Government’s chief economist Mark Cully.
PLS PILBF ALTAF AJM

 
Lithium worth ‘hundreds of billions’ to WA

2018-10-01 perthnow.com.au
AUSTRALIA’S chief resource economist says WA could earn “hundreds of billions of dollars” by taking advantage of its battery-making mineral wealth but has warned governments must act quickly to capitalise on the opportunity.
PLS PILBF

 
Pilbara Minerals’ first shipment from Pilgangoora sets sail

2018-10-01 australianmining.com.au
Pilbara Minerals has loaded its maiden shipment of 8800t of spodumene concentrate from the Pilgangoora lithium-tantalum project in Western Australia to its charter vessel, the M.V. Pola Devora.
PLS PILBF

 
WA mining job market 'warming up' but wont hit boom demand levels

2018-09-27 theage.com.au
The operations boss behind one of the state’s biggest lithium mines says the mining job market is ‘warming up’ but a crippling skills shortage on the same level as the previous boom is not expected.
PLS PILBF

 
WA mining job market 'warming up' but wont hit boom demand levels

2018-09-27 watoday.com.au
The operations boss behind one of the state’s biggest lithium mines says the mining job market is ‘warming up’ but a crippling skills shortage on the same level as the previous boom is not expected.
PLS PILBF

 
WA mining job market 'warming up' but wont hit boom demand levels

2018-09-27 smh.com.au
The operations boss behind one of the state’s biggest lithium mines says the mining job market is ‘warming up’ but a crippling skills shortage on the same level as the previous boom is not expected.
PLS PILBF

 
Markets Live: Session ends flat

2018-09-26 watoday.com.au
The S&P/ASX 200 index has closed 0.9 points lower, a decline of 0.02 per cent, as energy stocks tried to counteract the down pull from the financial index. The Hang Seng index is down 1.6 per cent and the Shanghai composite is down 1.06 per cent.
MBL PLS WOPEF PILBF BSL 500413 LYSCF WPL BCHEY THOMASCOOK WOPEY BEPTF BPT BLSFY TCG LYSDY BLSFF SBM

 
Tesla - Lithium Supply Secured?

2018-09-24 seekingalpha
Lithium being mined from brine. It's the cheapest way to mine it, but not really the kind Ganfeng has access to, right now.
PLS PILBF

2
Miners push ASX higher as aged care stocks fall

2018-09-21 theage.com.au
The Australian sharemarket has closed the week higher as the US finally imposed additional tariffs against China, bringing an end to weeks of uncertainty.
PLS AOG PILBF RIO BLT RIO LYSCF BHPBF IGO IIDDY REG RTPPF BHP RIO LYSDY RTNTF BBL BHP BHPLF WNARF JRHHY EHE JHC WSA

2
Miners push ASX higher as aged care stocks fall

2018-09-21 smh.com.au
The Australian sharemarket has closed the week higher as the US finally imposed additional tariffs against China, bringing an end to weeks of uncertainty.
PLS AOG PILBF RIO BLT RIO LYSCF BHPBF IGO IIDDY REG RTPPF BHP RIO LYSDY RTNTF BBL BHP BHPLF WNARF JRHHY EHE JHC WSA

 
Pilbara Minerals readies product as it increases lithium-tantalum reserves at Pilgangoora in WA’s northwest

2018-09-17 proactiveinvestors.com.au
Pilbara Minerals Ltd (ASX:PLS) has increase proved and probable ore reserves by 35% at its wholly-owned Pilgangoora Lithium-Tantalum Project in Western Australia’s Pilbara region. Pilgangoora’s reserve is now 108.2 million tonnes grading 1.25% spodumene, 120ppm tantalum pentoxide and 1.17% iron oxide.
PLS PILBF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: Q7539C100